Publication date: Jan 10, 2025

The scientific evidence supporting recommendations for dietary supplement use to prevent or treat coronavirus disease 2019 (COVID-19) is not well-established. This cohort study investigates the relationship between dietary supplement usage and COVID-19 symptoms among 27,181 adults tested for COVID-19. Using data from surveys following COVID-19 testing, conducted by the University of Arkansas for Medical Sciences, associations between dietary supplement usage, symptomatology, and COVID-19 status were explored. The prevalence of supplement consumption among symptomatic individuals was significant, with non-Hispanic (NH)-White individuals showing higher usage rates. Among those testing positive for COVID-19, mainly asymptomatic cases, dietary supplement usage was increased (7. 8%), suggesting a proactive approach to supplementation. Symptomatic individuals with confirmed COVID-19 also showed heightened dietary supplement usage (37. 9%), indicating a response to perceived therapeutic benefits. Notably, respiratory symptoms such as cough (46. 2%), fever (31. 4%), and shortness of breath (8. 9%) correlated consistently with increased dietary supplement usage across different time points. Despite limitations such as varying test sensitivities and potential selection biases, this study offers valuable insights into individual health-seeking behaviors during the pandemic. Findings emphasize the importance of targeted public health interventions and education to address disparities in dietary supplement usage and promote evidence-based approaches to dietary supplementation. Further research is warranted to understand better the motivations and implications of dietary supplement usage in the context of the pandemic.

Semantics

Original Article